Open in web browser

You are subscribed to the FormularyWatch eNews.

FormularyWatch

Share

eNews Subscribe

More Subscriptions

FORMULARY WATCH

Cancer drug value

ASCO set to compare value of cancer drugs

The American Society of Clinical Oncology (ASCO) is asking for comments on its ASCO Value Framework, which compares the value of new cancer therapies with established treatments. Framework details

Cosentyx shows benefit over 1 year in psoriatic arthritis patients

Novartis’ injectable drug secukinumab (Cosentyx) showed significant improvements in treating psoriatic arthritis, according to a study published in The Lancet. Study investigator insights

CONTINUING EDUCATION

MTM essentials for COPD management: Part 1

This month's CE activity is part of a CPE series, Medication Therapy Management for the Patient with Respiratory Disease. From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to assist pharmacists in understanding the pathophysiology and pharmacologic treatment of COPD and to discuss how COPD is similar to and different from other chronic respiratory disorders.

To read and print the article with TEST QUESTIONS, click here.

To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the Session Code: 15DT31-KTJ28.

To login to the Online CE Center, go to:
https://web2.uconn.edu/pharmacyce/login.php.
To review your registration page or to register, go to:
https://web2.uconn.edu/pharmacyce/program_register.php.
For a full list of courses, go to:
http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

Are cancer prices linked to survival rates?

Researchers explore the relationship between cancer drug cost and the percentage improvement in end point. Study details

July 10, 2015

Related Articles

Continued advances in cancer outcomes unveiled at ASCO

Secukinumab improves skin clearance in PsA patients over widely used therapy

Resources

Get the latest FormularyWatch updates on drug approvals, current studies, and other findings.

Click for the latest Clinical News

Click here to contact Editorial. Sales, Reprints, Classified questions? Click here to contact the Sales Team.

ModernMedicine logo
UBM  logo

UBM MEDICA